162 participants
Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2015-01-07
- Start Date:
- 2008-09-30
- Completion:
- 2010-09-30
Conditions
- Ovarian Cancer
Interventions
- DRUG
- OTHER
No Results Yet